Richard D. Press, M.D., Ph.D.

Head Shot of Richard Press
click here
503 494-8307


A Selection of Dr. Press's Recent Publications:

1. Bcr-Abl RNA Levels At and After the Time of a Complete Cytogenetic Remission (CCR) Predict the Duration of CCR In Imatinib-Treated CML Patients. Blood 107: 4250-4256, 2006.

2. Mutations of the BCR-ABL-kinase domain occur in a minority of patients with stable complete cytogenetic response to imatinib. Leukemia 21: 489-493, 2007.

3. HFE C282Y homozygotes ages 25-29 years at HEIRS study initial screening. Genetic Testing 11 (3): 269-275, 2007.

4. A genome-wide linkage scan for iron phenotype quantitative trait loci: The HEIRS Family Study. Clinical Genetics 71: 518-29, 2007/

5. A Half-Log Increase in BCR-ABL RNA Predicts a Higher Risk of Relapse in Patients with Chronic Myeloid Leukemia with an Imatinib-Induced Complete Cytogenetic Response (CCR). Clin Cancer Research, 13 (20): 6136-6143, 2007.

6. An international study to standardize the detection and quantitation of BCR-ABL transcripts from stabilized peripheral blood preparations by quantitative RT-PCR. Haematologica 92: 970-973, 2007.

7. An Intron-Derived Insertion-Truncation Mutation in the BCR-ABL Kinase Domain in CML Patients Undergoing Kinase Inhibitor Therapy. J. Molec Diagn, 10: 177-180, 2008.

Selected Publications

"Significant clinical response to JAK1/2 inhibition in a patient with CSF3R-T618I-positive atypical chronic myeloid leukemia," Leukemia Research Reports (Vol: 3, Issue: 2, Page 67-69) - 2015

"Clinical implementation of next-generation sequencing," Clinical Advances in Hematology and Oncology (Vol: 12, Issue: 4, Page 263-265) - 2014

"BCR-ABL PCR testing in chronic myelogenous leukemia: Molecular diagnosis for targeted cancer therapy and monitoring," Expert Review of Molecular Diagnostics (Vol: 13, Issue: 7, Page 749-762) - 2013

"BCR-ABL1 RT-qPCR for monitoring the molecular response to tyrosine kinase inhibitors in chronic myeloid leukemia," Journal of Molecular Diagnostics (Vol: 15, Issue: 5, Page 565-576) - 2013

"Detection of BCR-ABL1 kinase domain mutations causing imatinib resistance in chronic myelogenous leukemia," Methods in Molecular Biology (Vol: 999, Page 25-39) - 2013


For Healthcare Professionals


  Email Richard Press

503 494-8307